133 related articles for article (PubMed ID: 9248749)
41. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
[TBL] [Abstract][Full Text] [Related]
42. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.
Madsen PO; Kjaer TB; Mosegaard A
Urology; 1977 Jun; 9(6):635-8. PubMed ID: 329522
[TBL] [Abstract][Full Text] [Related]
43. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
Karachalios GN; Georgiopoulos AN
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
[TBL] [Abstract][Full Text] [Related]
44. Review of the efficacy of oral norfloxacin in pyelonephritis and nosocomial urinary tract infection.
Corrado ML; Roylance PJ; Struble WE; Lancaster MS
Eur Urol; 1990; 17 Suppl 1():24-9. PubMed ID: 2191866
[TBL] [Abstract][Full Text] [Related]
45. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
Corrado ML; Grad C; Sabbaj J
Am J Med; 1987 Jun; 82(6B):70-4. PubMed ID: 3300314
[TBL] [Abstract][Full Text] [Related]
46. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Neringer R; Forsgren A; Hansson C; Ode B
Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
[TBL] [Abstract][Full Text] [Related]
47. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
Miller IM; Vogel R; Cook TJ; Wittreich J
Am J Ophthalmol; 1992 Jun; 113(6):638-44. PubMed ID: 1598954
[TBL] [Abstract][Full Text] [Related]
48. Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
Corrado ML; Hesney M; Struble WE; Brown KR; Eng RH; Landes R; Harrison L; Ryan J; Bolding OT
Eur Urol; 1990; 17 Suppl 1():34-9. PubMed ID: 2191867
[TBL] [Abstract][Full Text] [Related]
49. Norfloxacin: a three-day course for the treatment of urinary tract infection.
Ganguli LA; Keaney MG; Gould LJ
Drugs Exp Clin Res; 1985; 11(3):177-9. PubMed ID: 3836125
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections.
Scaglione F; Demartini G; Cocuzza C; Raschi S; Cogo R
Int J Clin Pharmacol Res; 1995; 15(3):121-5. PubMed ID: 8847153
[TBL] [Abstract][Full Text] [Related]
51. [Clinical studies of norfloxacin in urinary tract infections].
Matsuura T; Kurita T
Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
[TBL] [Abstract][Full Text] [Related]
52. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
53. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
54. Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
Cox CE
Am J Med; 1991 Dec; 91(6A):129S-133S. PubMed ID: 1662883
[TBL] [Abstract][Full Text] [Related]
55. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
Cherubin C; Stilwell S
Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
[TBL] [Abstract][Full Text] [Related]
56. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
[TBL] [Abstract][Full Text] [Related]
57. Treatment of urinary tract infection with norfloxacin. Analysis of cost.
Ramirez-Ronda C; Colon M; Saavedra S; Sabbaj J; Corrado ML
Am J Med; 1987 Jun; 82(6B):75-8. PubMed ID: 3300315
[TBL] [Abstract][Full Text] [Related]
58. A comparative study of cefotaxime sodium versus a combination of cefapirin and gentamicin in the prophylactic treatment of patients undergoing cholecystectomy.
Ker CG; Hou MF; Chen JS; Lee KT; Sheen PC; Akbary MA
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):711-5. PubMed ID: 2695726
[TBL] [Abstract][Full Text] [Related]
59. [Clinical efficacy of the antimicrobial drug furamag in nosocomial urinary tract infections].
Iakovlev SV; Suvorova MP; Kolendo SE; Burmistrova EN; Sergeeva EV; Cherkasova NA; Eremina LV
Ter Arkh; 2014; 86(10):65-72. PubMed ID: 25509895
[TBL] [Abstract][Full Text] [Related]
60. Norfloxacin use in urinary tract infection by urologists and infectious disease specialists.
Kunkel MJ; Iannini PB; Landes R; Harrison L; Wells G; Snow R; Schaeffer AJ; Goldstein EJ; Berman S
Eur Urol; 1990; 17 Suppl 1():30-3. PubMed ID: 2354709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
